Bausch + Lomb appoints Eduardo Alfonso, MD and Steven Collis to board, effective Jan 1, 2026

Bausch & Lomb Corp

Eduardo C. Alfonso, MD, and Steven H. Collis appointed to Bausch + Lomb board, effective Jan 1, 2026.
Appointments fill vacancies left by Brett Icahn and Gary Hu who departed in August 2025; board will have 10 directors.
Both new directors are independent under NYSE and TSX rules; no committee assignments announced.
Alfonso is a prominent ophthalmologist; Collis is former CEO of AmerisourceBergen (Fortune 10).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.